Multicentre randomised double blind placebo controlled trial assessing the effect of weekly risedronate on bone mineral density in adults with cystic fibrosis

Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis

“…The preliminary results of this study were presented at the European and North American Cystic Fibrosis conferences in 2010 [24,25].…”